BP Lipid 228 is an ionizable lipid. The dimethylamine lipid head enhances encapsulation of mRNA. The lipid has a C5 amide connection and two primary esters at C8 position relative to the amide nitrogen. The primary lipid tail has a mixture of 4 and 6 carbon tails. The lipid can be used for mRNA-based therapies which depends on the availability of a safe and efficient delivery vehicle. The pKa is 6.5. Reagent grade, for research use only.
Usually ships within 24 hours.